# Top 4 interesting findings — autophagy

**Snapshot:** 2026-05-16T11-17-23Z
**Source:** Researka DB Tier-2 search (`POST /api/v1/tier2/facts/search`, filter topic=autophagy) — LLM-extracted, no Tier-1 canonical facts loaded for this topic yet; findings may be off-target (e.g. chemistry papers using the molecule name) until canonical curation.
**Facts inspected:** 14
**Ranking:** validation * magnitude * precision * recency (deterministic, no LLM). Same-paper + same-sub_topic findings are collapsed; extra biomarkers from the same trial appear as supporting numerics under the headline.

**Sub-topic lanes detected:** facts grouped by `sub_topic` below — read each lane independently.

---

### Lane — `effect_size`


## #1 — score 63 · effect_size

**Finding:** autophagy flux was significantly less in injured versus uninjured muscles (-26%, P < 0.02).

- **Value:** -26.0%
- **Population:** mice
- **Intervention:** traumatic freeze injury
- **Source:** *Mitochondrial-specific autophagy linked to mitochondrial dysfunction following traumatic freeze injury in mice* — American Journal of Physiology-Cell Physiology (2019)
  · DOI: `10.1152/ajpcell.00123.2019`
- **Validator:** researka-tier2

- **Why it matters:** This reduction in autophagy flux after muscle injury highlights a potential therapeutic target for improving muscle repair in clinical settings.
- **Caution:** The study relied on a mouse injury model, which may not accurately mimic human muscle pathophysiology or recovery timelines.
- **Next question:** Does the decrease in autophagy flux directly impair muscle stem cell activation or myofiber regeneration in a time-dependent manner?

---

## #2 — score 60 · effect_size

**Finding:** 1.215 (1.149-1.286) (P < .001) in multivariate Cox regression analysis

- **Value:** 1.215HR
- **Population:** patients with lung adenocarcinoma
- **Intervention:** autophagy-related lncRNA survival model
- **Source:** *A novel autophagy‐related lncRNA survival model for lung adenocarcinoma* — Journal of Cellular and Molecular Medicine (2021)
  · DOI: `10.1111/jcmm.16582`
- **Validator:** researka-tier2
- **Same-trial supporting numerics:** 1.256HR (1.256 (1.196-1.320) (P < .001) in univariate Cox regression )

- **Why it matters:** The hazard ratio suggests that autophagy-related biomarkers could serve as prognostic indicators for lung adenocarcinoma patients, guiding personalized treatment plans.
- **Caution:** Multivariate Cox regression accounts for known variables, but residual confounding from unmeasured factors like lifestyle or co-morbidities remains possible.
- **Next question:** What is the mechanistic link between this autophagy marker and patient survival, and can it be targeted to improve outcomes in clinical trials?

---

### Lane — `mechanism`


## #3 — score 50 · mechanism

**Finding:** Inhibition of autophagy by silencing of the key autophagy gene, beclin 1 or 3-MA, further increased the cytotoxicity of this combinatorial treatment, suggesting that autophagy plays a cytoprotective role

- **Value:** 1.0OR
- **Population:** glioma cells
- **Intervention:** MK-2206 + gefitinib with autophagy inhibition (beclin 1 silencing or 3-MA)
- **Source:** *MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis* — Molecular Cancer Therapeutics (2011)
  · DOI: `10.1158/1535-7163.mct-11-0606`
- **Validator:** researka-tier2

- **Why it matters:** Inhibiting autophagy boosts the effectiveness of combinatorial cancer treatments, offering a strategy to overcome treatment resistance in glioma.
- **Caution:** Experiments were performed in glioma cell cultures, lacking the complexity of whole-organism biology and potential off-target effects in normal brain cells.
- **Next question:** Will autophagy inhibition in vivo enhance the efficacy of current glioma therapies without increasing systemic toxicity in animal models?

---

### Lane — `rate`


## #4 — score 40 · rate

**Finding:** a population (∼30%) of intracellular Mtb is tagged with ubiquitin and targeted to selective autophagy

- **Value:** 30.0%
- **Population:** intracellular Mtb in macrophages
- **Intervention:** ESX-1 secretion system perturbation
- **Source:** *Galectin-8 Senses Phagosomal Damage and Recruits Selective Autophagy Adapter TAX1BP1 To Control <i>Mycobacterium tuberculosis</i> Infection in Macrophages* — mBio (2021)
  · DOI: `10.1128/mbio.01871-20`
- **Validator:** —

- **Why it matters:** The selective autophagy of ubiquitin-tagged Mtb reveals a host defense mechanism that could be exploited to develop new anti-tuberculosis drugs.
- **Caution:** The observed rate was determined in isolated macrophages, which may not reflect the dynamics in human lung tissue during active infection or with co-infections.
- **Next question:** How can we enhance the ubiquitin tagging of Mtb to improve autophagic clearance in patients with active tuberculosis, and does this vary by bacterial strain?

---
